Literature DB >> 28526553

Hypothalamic regulation of the sleep/wake cycle.

Daisuke Ono1, Akihiro Yamanaka2.   

Abstract

Sleep is one of the most important physiological functions in mammals. It is regulated by not only homeostatic regulation but also circadian clock. Several neuropeptide-producing neurons located in the hypothalamus are implicated in the regulation of sleep/wakefulness. Among them, orexin/hypocretin-producing neurons (orexin neurons) are a crucial component for maintenance of wakefulness, because lack of orexin function results in narcolepsy, which is a sleep disorder. Recent findings have identified substances that excite or inhibit neural activity of orexin neurons. Furthermore neural projections of the neurons which release these substances have been revealed. In addition to orexin, melanin concentrating hormone (MCH)-producing neurons in the lateral hypothalamic area (LHA) are also implicated in the regulation of sleep/wakefulness. MCH neurons are active during sleep but become silent during wakefulness. Recently developed innovative methods including optogenetics and pharmacogenetics have provided substantial insights into the regulation of sleep/wakefulness. In vivo optical recordings and retrograde and anterograde tracing methods will allow us to understand additional details regarding important interactions between these two types of neurons in the LHA and other neurons in the brain. Finally we discuss the circadian clock and sleep/wake cycle. Understanding of the neural networks and its circadian modulation of sleep/wake cycles remain to be investigated.
Copyright © 2017 Elsevier Ireland Ltd and Japan Neuroscience Society. All rights reserved.

Entities:  

Keywords:  Lateral hypothalamus; MCH neurons; Optogenetics; Orexin neurons; Sleep/wake

Mesh:

Substances:

Year:  2017        PMID: 28526553     DOI: 10.1016/j.neures.2017.03.013

Source DB:  PubMed          Journal:  Neurosci Res        ISSN: 0168-0102            Impact factor:   3.304


  15 in total

Review 1.  Sleep-mediated regulation of reward circuits: implications in substance use disorders.

Authors:  Rong Guo; Dylan Thomas Vaughan; Ana Lourdes Almeida Rojo; Yanhua H Huang
Journal:  Neuropsychopharmacology       Date:  2022-06-16       Impact factor: 7.853

2.  Microglia modulate hippocampal synaptic transmission and sleep duration along the light/dark cycle.

Authors:  Giorgio Corsi; Katherine Picard; Maria Amalia di Castro; Stefano Garofalo; Federico Tucci; Giuseppina Chece; Claudio Del Percio; Maria Teresa Golia; Marcello Raspa; Ferdinando Scavizzi; Fanny Decoeur; Clotilde Lauro; Mara Rigamonti; Fabio Iannello; Davide Antonio Ragozzino; Eleonora Russo; Giovanni Bernardini; Agnès Nadjar; Marie Eve Tremblay; Claudio Babiloni; Laura Maggi; Cristina Limatola
Journal:  Glia       Date:  2021-09-06       Impact factor: 8.073

3.  Persistent effects of the orexin-1 receptor antagonist SB-334867 on motivation for the fast acting opioid remifentanil.

Authors:  Aida Mohammadkhani; Morgan H James; Caroline B Pantazis; Gary Aston-Jones
Journal:  Brain Res       Date:  2019-09-14       Impact factor: 3.252

4.  Evaluation of SAMP8 Mice as a Model for Sleep-Wake and Rhythm Disturbances Associated with Alzheimer's Disease: Impact of Treatment with the Dual Orexin (Hypocretin) Receptor Antagonist Lemborexant.

Authors:  Carsten T Beuckmann; Hiroyuki Suzuki; Erik S Musiek; Takashi Ueno; Toshitaka Sato; Masahiro Bando; Yoshihide Osada; Margaret Moline
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

5.  Sleep Disturbance in Mild Cognitive Impairment and Association With Cognitive Functioning. A Case-Control Study.

Authors:  Katie Palmer; Micaela Mitolo; Francesca Burgio; Francesca Meneghello; Annalena Venneri
Journal:  Front Aging Neurosci       Date:  2018-11-09       Impact factor: 5.750

6.  Lateral hypothalamic neurotensin neurons promote arousal and hyperthermia.

Authors:  Fumito Naganuma; Daniel Kroeger; Sathyajit S Bandaru; Gianna Absi; Joseph C Madara; Ramalingam Vetrivelan
Journal:  PLoS Biol       Date:  2019-03-20       Impact factor: 8.029

7.  Assessing the treatment of cannabidiolic acid methyl ester: a stable synthetic analogue of cannabidiolic acid on c-Fos and NeuN expression in the hypothalamus of rats.

Authors:  Eric Murillo-Rodríguez; Diana Millán-Aldaco; Gloria Arankowsky-Sandoval; Tetsuya Yamamoto; Roger G Pertwee; Linda Parker; Raphael Mechoulam
Journal:  J Cannabis Res       Date:  2021-07-12

8.  RPamide neuropeptides NLP-22 and NLP-2 act through GnRH-like receptors to promote sleep and wakefulness in C. elegans.

Authors:  Petrus Van der Auwera; Lotte Frooninckx; Kristen Buscemi; Ryan T Vance; Jan Watteyne; Olivier Mirabeau; Liesbet Temmerman; Wouter De Haes; Luca Fancsalszky; Alexander Gottschalk; David M Raizen; Matthew D Nelson; Liliane Schoofs; Isabel Beets
Journal:  Sci Rep       Date:  2020-06-18       Impact factor: 4.996

9.  CCL2/CCR2 system in neuroepithelial radial glia progenitor cells: involvement in stimulatory, sexually dimorphic effects of maternal ethanol on embryonic development of hypothalamic peptide neurons.

Authors:  Guo-Qing Chang; Olga Karatayev; Devi Sai Sri Kavya Boorgu; Sarah F Leibowitz
Journal:  J Neuroinflammation       Date:  2020-07-10       Impact factor: 8.322

Review 10.  Saporin from Saponaria officinalis as a Tool for Experimental Research, Modeling, and Therapy in Neuroscience.

Authors:  Alexey P Bolshakov; Mikhail Yu Stepanichev; Yulia V Dobryakova; Yulia S Spivak; Vladimir A Markevich
Journal:  Toxins (Basel)       Date:  2020-08-25       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.